Smoking in United States of America
In the United States of America, smoking is allowed but tobacco products should follow some regulations. Under these regulations, health warnings on tobacco packaging including cigarettes are mandatory, the minimum legal age for their sales is 21 years, and there are no federal legal restrictions on smoking in public places. While tobacco advertising is regulated, not all forms of their advertising are banned. An excise tax of 32.16% with a total taxation rate of 37.36% is applied on cigarettes. Cigarettes can legally be sold with authorised documents. They may also be purchased through vending machines as well as through online channels. Importing cigarettes for trade is allowed with an appropriate import license. Despite these control measures, prevalence data show that smoking remains an important public health issue in the United States. There were 39.8 million current smokers in the country in 2024. This represents an overall adult smoking prevalence of 14.1%, with higher prevalence among men (17.1%) than among women (11.1%). In comparison, the overall current smoking prevalence was 12.3% in 2022. The adult daily smoking prevalence was recorded to be 10.01% in 2020. Smoking-related mortality also remains significant in the country. In 2021, smoking resulted in 360,370 deaths, including 216,986 male deaths and 143,383 female deaths. This shows that smoking accounted for 10.38% of all deaths in the United States in 2021, with a higher rate among men (11.9%) than among women (8.7%).
Read articles from United States of America
August 10, 2026 by regulatorwatch.com
Lumped In | Nicotine-Free Vapes, Guilt by Association? | RegWatch
Nicotine-free vapes show how easily regulation can drift from risk assessment into guilt by association. A product does not become equivalent to smoking simply because it sits near nicotine in the public debate. If rules are based on category suspicion rather than exposure, use and actual harm, they risk confusing consumers and weakening trust in public health. Regulation should be precise enough to distinguish what products contain, how they are used and what risks they genuinely present.
August 10, 2026 by regulatorwatch.com
Lumped In | Nicotine-Free Vapes, Guilt by Association? | RegWatch
Nicotine-free vapes show how easily regulation can drift from risk assessment into guilt by association. A product does not become equivalent to smoking simply because it sits near nicotine in the public debate. If rules are based on category suspicion rather than exposure, use and actual harm, they risk confusing consumers and weakening trust in public health. Regulation should be precise enough to distinguish what products contain, how they are used and what risks they genuinely present.
August 07, 2026 by clearingtheair.eu
Exclusive vaping rises 18.8% a year as US adults move away from smoking, study shows
The movement away from smoking is already happening in the data. A study showing exclusive vaping rising by 18.8% a year among US adults suggests that many people are not simply adding nicotine products, but replacing cigarettes with smoke-free alternatives. That distinction matters: full switching is where harm reduction has the greatest potential. Policy should pay attention to these behavioural shifts instead of treating all nicotine use as a failure.
August 07, 2026 by substack.com
Responses to FDA Tobacco Regulatory Actions
Regulatory meetings should be judged by whether they bring public health closer to real-world solutions. Responses to the FDA’s tobacco regulatory agenda show how wide the gap remains between precaution, evidence and the needs of adults who smoke. If the process treats lower-risk nicotine products mainly as a threat, it risks missing their potential role in reducing exposure to combustible tobacco. Better regulation starts with listening to evidence, consumers and unintended consequences — not only institutional caution.
August 06, 2026 by tobaccoreporter.com
Experts Recommend Physicians Use Vape to Help Smokers Quit
Doctors are often the first trusted voice a smoker hears when trying to quit. If evidence supports vaping as a cessation aid, clinicians should be able to discuss it honestly rather than avoid the subject because of stigma. The goal is not to promote nicotine use, but to help people move away from combustible tobacco when other methods have not worked. Smoking cessation advice should reflect the full range of evidence-based options available to adults.
July 31, 2026 by healthday.com
Vaping Is Likely Reshaping The Future Of Cancer In The US, Study Argues
Cancer risk should not be discussed through headlines alone. New modelling on vaping and future cancer burden raises important questions about long-term outcomes, but it also depends on the comparison being made: continued smoking, complete cessation, dual use or full switching. The crucial distinction remains combustion, which drives the overwhelming burden of tobacco-related cancer. Public health communication should examine emerging risks without obscuring the far greater danger of cigarettes.
July 31, 2026 by medicalxpress.com
Experts say it's time to include nicotine e-cigarettes in smoking cessation conversations
A lower-nicotine cigarette may change the product, but it does not remove the need for a serious quit conversation. Smokers still need clear support, realistic options and honest information about why burning tobacco causes so much harm. Any move to reduce nicotine in cigarettes should be paired with access to effective cessation tools, including lower-risk nicotine alternatives where appropriate. Otherwise, policy may weaken dependence on paper while leaving people without a workable route away from smoking.
July 30, 2026 by daily-pouch.com
Does Vaping Impair Skin Healing?
The skin-healing question sits in a wider clinical grey area: what should patients be told when the evidence is still developing? Vaping should not be presented as harmless, but neither should it be discussed as though it carries the same exposure profile as smoking. For wound recovery, surgery and tissue repair, the useful message is precision: identify possible risks, explain uncertainty, and keep combustion in a separate risk category. Clinical advice is strongest when it helps people understand degrees of harm, not just avoid nuance.
July 28, 2026 by regulatorwatch.com
Striking Contrast | Science, Politics & the Battle Over Nicotine Pouches | RegWatch
Nicotine pouches sit at the intersection of science and politics — and the two are not always moving in the same direction. Evidence can help distinguish smoke-free products from cigarettes, but political pressure often pushes them into the same moral category. That contrast matters because regulation shaped by fear may ignore differences in exposure, risk and use. The battle over pouches is ultimately a test of whether policy can follow evidence when the politics becomes uncomfortable.
July 28, 2026 by regulatorwatch.com
Striking Contrast | Science, Politics & the Battle Over Nicotine Pouches | RegWatch
Nicotine pouches sit at the intersection of science and politics — and the two are not always moving in the same direction. Evidence can help distinguish smoke-free products from cigarettes, but political pressure often pushes them into the same moral category. That contrast matters because regulation shaped by fear may ignore differences in exposure, risk and use. The battle over pouches is ultimately a test of whether policy can follow evidence when the politics becomes uncomfortable.